{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:35:32Z","timestamp":1792751732387,"version":"4.5.0"},"reference-count":356,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001428","name":"Amity University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.bcp.2023.115437","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:25:51Z","timestamp":1675045551000},"page":"115437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators"],"prefix":"10.1016","volume":"209","author":[{"given":"Nusrath","family":"Yasmeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishnan","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan S","family":"Lakhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpender K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayalakshmi","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115437_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0010","unstructured":"WHO, \u201cWHO Coronavirus (COVID-19) Dashboard.\u201d https:\/\/covid19.who.int\/ (accessed Sep. 30, 2022)."},{"key":"10.1016\/j.bcp.2023.115437_b0015","doi-asserted-by":"crossref","unstructured":"U. Parthasarathy, R. Martinelli, E. H. Vollmann, K. Best, and A. G. Therien, \u201cThe impact of DAMP-mediated inflammation in severe COVID-19 and related disorders,\u201d Biochem. Pharmacol., vol. 195, no. October 2021, p. 114847, 2022, doi: 10.1016\/j.bcp.2021.114847.","DOI":"10.1016\/j.bcp.2021.114847"},{"key":"10.1016\/j.bcp.2023.115437_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114057","article-title":"Targeting Neprilysin (NEP) pathways: a potential new hope to defeat COVID-19 ghost","volume":"178","author":"Mohammed El Tabaa","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"255","key":"10.1016\/j.bcp.2023.115437_b0025","first-page":"1","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u2018cytokine storm\u2019: molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0035","first-page":"pp","article-title":"Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm","volume":"12","author":"Morgulchik","year":"2021","journal-title":"Interface Focus"},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.116.307308","article-title":"Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology","volume":"119","author":"Sansbury","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2023.115437_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100894","article-title":"The atlas of inflammation resolution (AIR)","volume":"74","author":"Serhan","year":"2020","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bcp.2023.115437_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115437_b0055","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: The beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"issue":"July","key":"10.1016\/j.bcp.2023.115437_b0060","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3389\/fimmu.2019.01699","article-title":"Activation of resolution pathways to prevent and fight chronic inflammation: lessons from asthma and inflammatory bowel disease","volume":"10","author":"Barnig","year":"2019","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.bcp.2023.115437_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810719","article-title":"Involvement of inflammation and its resolution in disease and therapeutics","volume":"23","author":"Alfaro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115437_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/949157","article-title":"Innate immune cells in liver inflammation","volume":"2012","author":"Liaskou","year":"2012","journal-title":"Hindawi Publ. Corp. Mediat. Inflamm."},{"key":"10.1016\/j.bcp.2023.115437_b0075","first-page":"1126","article-title":"Reactive oxygen species in inflammation and tissue","author":"Mittal","year":"2014","journal-title":"Injury"},{"key":"10.1016\/j.bcp.2023.115437_b0080","doi-asserted-by":"crossref","unstructured":"V. Gudernatsch, S. Anna, Novel resolution mediators of severe systemic in flammation, 2020, pp. 31\u201341.","DOI":"10.2147\/ITT.S243238"},{"issue":"June","key":"10.1016\/j.bcp.2023.115437_b0085","article-title":"Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation","volume":"205","author":"Kusiak","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"June","key":"10.1016\/j.bcp.2023.115437_b0090","article-title":"Blame the signaling: role of cAMP for the resolution of inflammation","volume":"159","author":"Tavares","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2023.115437_b0095","doi-asserted-by":"crossref","unstructured":"L.A. Abdulkhaleq, M.A. Assi, R. Abdullah, M.N.M. Hezmee, The crucial roles of inflammatory mediators in inflammation\u00a0: a review 11 (2018) 627\u2013635, doi: 10.14202\/vetworld.2018.627-635.","DOI":"10.14202\/vetworld.2018.627-635"},{"key":"10.1016\/j.bcp.2023.115437_b0100","doi-asserted-by":"crossref","unstructured":"R. Highlights, O.F. Atvb, Endothelial Response to Pathophysiological, no. November, 2019, doi: 10.1161\/ATVBAHA.119.312580.","DOI":"10.1161\/ATVBAHA.119.312580"},{"key":"10.1016\/j.bcp.2023.115437_b0105","doi-asserted-by":"crossref","unstructured":"J.V. Sarma, P.A. Ward, The complement system, 2011, pp. 227\u2013235, doi: 10.1007\/s00441-010-1034-0.","DOI":"10.1007\/s00441-010-1034-0"},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00441-014-1809-9","article-title":"Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies","volume":"355","author":"Leick","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"June","key":"10.1016\/j.bcp.2023.115437_b0115","first-page":"1","article-title":"Vascular endothelial galectins in leukocyte trafficking","volume":"12","author":"Lightfoot","year":"2021","journal-title":"Front. Immunol."},{"issue":"June 2000","key":"10.1016\/j.bcp.2023.115437_b0120","first-page":"107","article-title":"Adhesion molecules: the path to a new understanding of acute inflammation","volume":"15","author":"Walzog","year":"2022","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.bcp.2023.115437_b0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.ai.2015.09.001","article-title":"Mechanism of diapedesis: importance of the transcellular route","volume":"129","author":"Filippi","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0130","doi-asserted-by":"crossref","unstructured":"I. Kourtzelis, I. Mitroulis, J. Von Renesse, G. Hajishengallis, T. Chavakis, From leukocyte recruitment to resolution of inflammation\u00a0: the cardinal role of integrins, vol. 102, no. September, 2017, doi: 10.1189\/jlb.3MR0117-024R.","DOI":"10.1189\/jlb.3MR0117-024R"},{"key":"10.1016\/j.bcp.2023.115437_b0135","doi-asserted-by":"crossref","unstructured":"M.V.S. Nourshargh, Neutrophil Transmigration\u00a0: Emergence of an Adhesive Cascade within Venular, 2013, pp. 336\u2013347, doi: 10.1159\/000346659.","DOI":"10.1159\/000346659"},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0140","first-page":"pp. 1-","article-title":"Leukocyte transcellular diapedesis: Rap1b is in control","volume":"3","author":"Filippi","year":"2015","journal-title":"Tissue Barriers ISSN"},{"key":"10.1016\/j.bcp.2023.115437_b0145","doi-asserted-by":"crossref","unstructured":"M. Metzemaekers, M. Gouwy, P. Proost, Neutrophil chemoattractant receptors in health and disease, Cell. Mol. Immunol. 2020, doi: 10.1038\/s41423-020-0412-0.","DOI":"10.1038\/s41423-020-0412-0"},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b0150","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.immuni.2014.10.008","article-title":"Review leukocyte migration into inflamed tissues","volume":"41","author":"Nourshargh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2023.115437_b0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00441-018-2802-5","article-title":"Neutrophils: multitasking first responders of immunity and tissue homeostasis","volume":"371","author":"Jenne","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"February","key":"10.1016\/j.bcp.2023.115437_b0160","first-page":"1","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types ?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2023.115437_b0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1183\/09059180.00012514","article-title":"Innate immunity is a key factor for the resolution of inflammation in asthma","volume":"24","author":"Barnig","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"June","key":"10.1016\/j.bcp.2023.115437_b0170","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1111\/bph.15164","article-title":"Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to","volume":"177","author":"Sousa","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"June","key":"10.1016\/j.bcp.2023.115437_b0175","first-page":"1","article-title":"specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities","volume":"12","author":"Lavy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0180","first-page":"52","article-title":"Inflammation and its resolution and the musculoskeletal system","volume":"10","author":"Gallo","year":"2017","journal-title":"J. Orthop. Transl."},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0185","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"issue":"112422","key":"10.1016\/j.bcp.2023.115437_b0190","first-page":"1","article-title":"Neutrophil accumulation within tissues: a damage x healing dichotomy","volume":"145","author":"Oliveira-costa","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"21","key":"10.1016\/j.bcp.2023.115437_b0195","first-page":"1","article-title":"The neutrophil: the underdog that packs a punch in the fight against cancer","volume":"21","author":"Avtenyuk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","article-title":"Mediators of the resolution of the inflammatory response","volume":"40","author":"Sugimoto","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/829851","article-title":"Switching off key signaling survival molecules to switch on the resolution of inflammation","volume":"2014","author":"Perez","year":"2014","journal-title":"Hindawi Publ. Corp. Mediat. Inflamm."},{"key":"10.1016\/j.bcp.2023.115437_b0210","doi-asserted-by":"crossref","unstructured":"D. Atri, Chiraz;Guerfali, Fatma Z.;Laouini, Role of human macrophage polarization in inflammation during infectious diseases, Int. J. Mol. Sci. Rev., vol. 19, no. 6, pp. 1801\u20131815, 2018, doi: 10.3390\/ijms19061801.","DOI":"10.3390\/ijms19061801"},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0186964","article-title":"Prolonged immune alteration following resolution of acute inflammation in humans","volume":"12","author":"Motwani","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bcp.2023.115437_b0220","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2014-03-562710","article-title":"Resolution of acute inflammation bridges the gap between innate and adaptive immunity Resolution of acute in fl ammation bridges the gap between innate and adaptive immunity","volume":"124","author":"Newson","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cell.2015.08.030","article-title":"Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity","volume":"163","author":"Da Fonseca","year":"2015","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.bcp.2023.115437_b0230","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.celrep.2017.08.098","article-title":"Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1 \/ mPGES-1- inflammatory resolution triggers a prolonged phase of immune suppression through COX-1 \/ mPGES-1-derived prostaglandin E 2","volume":"20","author":"Newson","year":"2017","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0235","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bph.14587","article-title":"Lipid mediators in immune regulation and resolution","volume":"176","author":"Gilroy","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0240","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2023.115437_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121114","article-title":"Resolution of inflammation in bone regeneration: from understandings to therapeutic applications","volume":"277","author":"Newman","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2023.115437_b0250","doi-asserted-by":"crossref","unstructured":"W. Ansar, S. Ghosh, Inflammation and inflammatory diseases, markers, and mediators: Role of CRP in some inflammatory diseases. 2016. doi: 10.1007\/978-81-322-2680-2.","DOI":"10.1007\/978-81-322-2680-2_4"},{"issue":"June","key":"10.1016\/j.bcp.2023.115437_b0255","first-page":"1","article-title":"Inflammation: The common pathway of stress-related diseases","volume":"11","author":"Liu","year":"2017","journal-title":"Front. Hum. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2796.2010.02235.x","article-title":"Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination","volume":"268","author":"Norling","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bcp.2023.115437_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114825","article-title":"Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages","volume":"195","author":"Kretzer","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0270","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/bph.14336","article-title":"Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology","volume":"176","author":"Dalli","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.bcp.2023.115437_b0275","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/febs.16266","article-title":"Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections","volume":"289","author":"Jordan","year":"2022","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-36679-4","article-title":"Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation","volume":"8","author":"Norris","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0285","article-title":"On the biosynthesis of specialized pro-resolving mediators in human neutrophils and the influence of cell integrity","volume":"1867","author":"Mainka","year":"2022","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bcp.2023.115437_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","article-title":"New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration","volume":"64","author":"Serhan","year":"2018","journal-title":"Mol. Aspects Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOL.0000000000000262","article-title":"n-3 Fatty acid supplementation and proresolving mediators of inflammation","volume":"27","author":"Barden","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0300","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0305","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbalip.2018.08.010","article-title":"Phospholipase A 2 catalysis and lipid mediator lipidomics","volume":"1864","author":"Mouchlis","year":"2019","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"issue":"11","key":"10.1016\/j.bcp.2023.115437_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10112963","article-title":"Dynamic role of phospholipases A2 in health and diseases in the central nervous system","volume":"10","author":"Sun","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b0315","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbalip.2014.09.002","article-title":"Transcellular biosynthesis of eicosanoid lipid mediators","volume":"1851","author":"Capra","year":"2014","journal-title":"BBA - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bcp.2023.115437_b0320","article-title":"Epoxy fatty acids are promising targets for treatment of pain, cardiovascular disease and other indications characterized by mitochondrial dysfunction","volume":"1274","author":"McReynolds","year":"2020","journal-title":"Endoplasmic Stress and Inflammation"},{"key":"10.1016\/j.bcp.2023.115437_b0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prostaglandins.2014.09.001","article-title":"Prostaglandins and other lipid mediators the role of long chain fatty acids and their epoxide metabolites in nociceptive signaling","volume":"113\u2013115","author":"Wagner","year":"2014","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bcp.2023.115437_b0330","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2023.115437_b0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.prostaglandins.2017.06.003","article-title":"The novel lipid mediator PD1n-3 DPA: an overview of the structural elucidation, synthesis, biosynthesis and bioactions","volume":"133","author":"Hansen","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/acsptsci.9b00097","article-title":"Therapeutic potential of lipoxin a4in chronic inflammation: focus on cardiometabolic disease","volume":"3","author":"Fu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"17 I","key":"10.1016\/j.bcp.2023.115437_b0345","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: Novel series of biologically active compounds formed from arachidonic acid in human leukocytes","volume":"81","author":"Serhan","year":"1984","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2023.115437_b0350","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1100\/tsw.2010.113","article-title":"Lipoxin and aspirin-triggered lipoxins","volume":"10","author":"Romano","year":"2010","journal-title":"ScientificWorldJournal"},{"issue":"3 SPEC. ISS","key":"10.1016\/j.bcp.2023.115437_b0355","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.prostaglandins.2007.01.003","article-title":"5-Lipoxygenase: Regulation and possible involvement in atherosclerosis","volume":"83","author":"R\u00e5dmark","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b0360","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1590\/S0100-879X2001000500002","article-title":"Mechanisms in anti-inflammation and resolution: The role of lipoxins and aspirin-triggered lipoxins","volume":"34","author":"Fierro","year":"2001","journal-title":"Brazilian J. Med. Biol. Res."},{"issue":"March","key":"10.1016\/j.bcp.2023.115437_b0365","first-page":"1","article-title":"Formation, signaling and occurrence of specialized pro-resolving lipid mediators\u2014what is the evidence so far?","volume":"13","author":"Schebb","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115437_b0370","doi-asserted-by":"crossref","unstructured":"B. McMahon, C. Godson, Lipoxins: Endogenous regulators of inflammation, Am. J. Physiol. - Ren. Physiol. 286(2) (2004) 189\u2013201, doi: 10.1152\/ajprenal.00224.2003.","DOI":"10.1152\/ajprenal.00224.2003"},{"key":"10.1016\/j.bcp.2023.115437_b0375","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science (80-.)"},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0380","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/154411130301400102","article-title":"Lipoxins in chronic inflammation alpdogan","volume":"14","author":"Van Dyke","year":"2003","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.bcp.2023.115437_b0385","doi-asserted-by":"crossref","unstructured":"T. R. Green, Abigail R;Freedman, Cody;Tena, Jennyfer;Tourdot, Benjamin E., Liu, Benjamin;Holinstat, Michael;Holman, \u201c5S,15S-Dihydroperoxyeicosatetraenoic acid (5,15-diHpETE) as a Lipoxin Intermediate: Reactivity and Kinetics with Human Leukocyte 5-Lipoxygenase, Platelet 12-Lipoxygenase, and Reticulocyte 15-Lipoxygenase-1, Biochemistry, vol. 57, no. 48, pp. 6726\u20136734, 2018, doi: 10.1021\/acs.biochem.8b00889.5S.","DOI":"10.1021\/acs.biochem.8b00889"},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0390","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1021\/ja00288a032","article-title":"Enantiospecific and stereospecific synthesis of lipoxin A. stereochemical assignment of the natural lipoxin A and its possible biosynthesis","volume":"107","author":"Adams","year":"1985","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2023.115437_b0395","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0090-6980(02)00047-3","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: An update and role in anti-inflammation and pro-resolution","volume":"68\u201369","author":"Serhan","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0400","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1432-1033.1991.tb16137.x","article-title":"On the mechanism of transcellular lipoxin formation in human platelets and granulocytes","volume":"199","author":"Edenius","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2023.115437_b0405","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcp.2016.08.023","article-title":"BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase\/5-lipoxygenase-activating protein (FLAP) complex assembly","volume":"119","author":"Garscha","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"49","key":"10.1016\/j.bcp.2023.115437_b0410","doi-asserted-by":"crossref","first-page":"40609","DOI":"10.1074\/jbc.M507045200","article-title":"Phosphorylation by protein kinase A inhibits nuclear import of 5-lipoxygenase","volume":"280","author":"Luo","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2023.115437_b0415","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1096\/fj.15-275487","article-title":"Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein","volume":"29","author":"Lehmann","year":"2015","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.bcp.2023.115437_b0420","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/bph.12625","article-title":"The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP)","volume":"171","author":"Pergola","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115437_b0425","doi-asserted-by":"crossref","unstructured":"C. Kretzer et al., Shifting the biosynthesis of leukotrienes toward specialized pro-resolving mediators by the 5-lipoxygenase-activating protein (FLAP) antagonist BRP-201, J. Inflamm. Res., vol. 15, no. December 2021, pp. 911\u2013925, 2022, doi: 10.2147\/JIR.S345510.","DOI":"10.2147\/JIR.S345510"},{"issue":"21","key":"10.1016\/j.bcp.2023.115437_b0430","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Cl\u00e0ria","year":"1995","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b0435","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/01.CIR.0000140985.89766.CB","article-title":"Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone","volume":"110","author":"Von Der Weid","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b0440","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","article-title":"Novel lipid mediators promote resolution of acute inflammation: Impact of aspirin and statins","volume":"107","author":"Spite","year":"2010","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b0445","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood-2013-04-496661","article-title":"A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation","volume":"122","author":"Brancaleone","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b0450","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.bbamem.2011.12.013","article-title":"Esterified eicosanoids: generation, characterization and function","volume":"1818","author":"Hammond","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"16","key":"10.1016\/j.bcp.2023.115437_b0455","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1073\/pnas.87.16.6248","article-title":"Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: Agonist-induced deacylation and transformation of stored hydroxyeicosanoids","volume":"87","author":"Brezinski","year":"1990","journal-title":"PNAS"},{"issue":"35","key":"10.1016\/j.bcp.2023.115437_b0460","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1073\/pnas.1404372111","article-title":"Phospholipase A2 regulates eicosanoid class switching during inflammasome activation","volume":"111","author":"Norris","year":"2014","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b0465","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Charles N and petasis, \u201cresolvins and protectins in inflammation-resolution\u201d","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2023.115437_b0470","doi-asserted-by":"crossref","unstructured":"B.C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, K. Gronert, Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2 \u2013 nonsteroidal antiinflammatory drugs and transcellular processing 192(8) (2000).","DOI":"10.1084\/jem.192.8.1197"},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b0475","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"issue":"November","key":"10.1016\/j.bcp.2023.115437_b0480","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2006.09.011","article-title":"Resolvin E2: identification and anti-inflammatory actions : pivotal role of human 5-lipoxygenase in resolvin e series biosynthesis","volume":"13","author":"Tjonahen","year":"2006","journal-title":"chemsitry Biol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0485","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115437_b0490","first-page":"1","article-title":"Stereoselective syntheses and biological activities of E-series resolvins","author":"Vik","year":"2021","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b0495","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S0029665113003030","article-title":"Deciphering the role of omega-3 polyunsaturated fatty acid- derived lipid mediators in health and disease","volume":"72","author":"Spite","year":"2013","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.bcp.2023.115437_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9061391","article-title":"Bioactive lipid signaling in cardiovascular disease, development, and regeneration","volume":"9","author":"Wasserman","year":"2020","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.bcp.2023.115437_b0505","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1074\/jbc.M112.340612","article-title":"Identification and structure determination of novel anti-inflammatory mediator resolvin E3","volume":"287","author":"Isobe","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115437_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.631319","article-title":"A new E-series resolvin: RvE4 stereochemistry and function in efferocytosis of in fl ammation-resolution","volume":"11","author":"Libreros","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0515","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1021\/acs.joc.0c02913","article-title":"Stereoselective synthesis and structural confirmation of the specialized pro-resolving mediator resolvin E4","volume":"86","author":"Reinertsen","year":"2021","journal-title":"J. Org. chemsitry"},{"key":"10.1016\/j.bcp.2023.115437_b0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aax4895","article-title":"Resolution metabolomes activated by hypoxic environment","volume":"5","author":"Norris","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2023.115437_b0525","first-page":"1","article-title":"N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer\u2019s disease","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2023.115437_b0530","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1152\/physrev.00026.2017","article-title":"Specialized proresolving mediators in innate and adaptive immune responses in airway diseases","volume":"98","author":"Krishnamoorthy","year":"2018","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0535","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins : a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp.Med"},{"issue":"13","key":"10.1016\/j.bcp.2023.115437_b0540","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer stereochemical assignments, anti-inflammatoryproperties, and enzymaticinactivation","volume":"282","author":"Sun","year":"2007","journal-title":"TheJournal Biol. Chem."},{"issue":"17","key":"10.1016\/j.bcp.2023.115437_b0545","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17 S -resolvins generated from docosahexaenoic acid in murine brain, human blood","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115437_b0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/chem.202103857","article-title":"Stereoselective synthesis, configurational assignment and biological evaluations of the lipid mediator RvD2 n-3 DPA","volume":"28","author":"Reinertsen","year":"2022","journal-title":"Chem Eur J"},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0555","first-page":"1476","article-title":"Resolving inflammation: synthesis, configurational assignment and biological evaluations of RvD1n-3 DPA","volume":"25","author":"Tungen","year":"2019","journal-title":"Chemsitry"},{"issue":"7268","key":"10.1016\/j.bcp.2023.115437_b0560","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis Matthew","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115437_b0565","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1016\/j.tetlet.2004.09.129","article-title":"First total synthesis of 7 (S), 16 (R), 17 (S) -Resolvin D2, a potent anti-inflammatory lipid mediator","volume":"45","author":"Rodrigues","year":"2004","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bcp.2023.115437_b0570","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prostaglandins.2004.03.005","article-title":"Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis Charles","volume":"73","author":"Serhan","year":"2004","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bcp.2023.115437_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep01940","article-title":"Novel n-3 immunoresolvents: structures and actions","volume":"3","author":"Dalli","year":"2013","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b0580","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/ol400484u","article-title":"Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin- triggered 17R-epimer","volume":"15","author":"Winkler","year":"2013","journal-title":"Org. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0585","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcp.2023.115437_b0590","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.plefa.2016.01.001","article-title":"Resolvin D3 multi-level proresolving actions are host protective during infection","volume":"138","author":"Norris","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"9","key":"10.1016\/j.bcp.2023.115437_b0595","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jid.2018.03.1498","article-title":"Biosynthesis of D-series resolvins in skin provides insights into their role in tissue repair","volume":"138","author":"Hellmann","year":"2018","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.bcp.2023.115437_b0600","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/JLB.3MI0617-254R","article-title":"Frontline science: structural insights into resolvin D4 actions and further metabolites via a new total organic synthesis and validation","volume":"103","author":"Winkler","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"18972","key":"10.1016\/j.bcp.2023.115437_b0605","first-page":"1","article-title":"Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance","volume":"6","author":"Winkler","year":"2016","journal-title":"Sci. Reportscientifc"},{"key":"10.1016\/j.bcp.2023.115437_b0610","doi-asserted-by":"crossref","unstructured":"I. Ferreira, F. Falcato, N. Bandarra, and A. p Rauteur, Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation, Molecules 27(5) (2022) 2\u201349.","DOI":"10.3390\/molecules27051677"},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0615","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.2021013422","article-title":"Resolvin T-series reduce neutrophil extracellular traps","volume":"139","author":"Chiang","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tetlet.2019.151473","article-title":"First total syntheses of the pro-resolving lipid mediators 7(S),13(R),20(S)-Resolvin T1 and 7(S),13(R)-Resolvin T4","volume":"61","author":"Rodriguez","year":"2020","journal-title":"Tetrahedron Lett."},{"issue":"9","key":"10.1016\/j.bcp.2023.115437_b0625","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nm.3911","article-title":"Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections","volume":"21","author":"Dalli","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2023.115437_b0630","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1021\/acs.jnatprod.6b00634","article-title":"Synthesis of 13(R)-hydroxy-7Z,10Z,13R,14E,16Z,19Z docosapentaenoic acid (13R-HDPA) and its biosynthetic conversion to the 13-series resolvins","volume":"79","author":"Primdahl","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"20","key":"10.1016\/j.bcp.2023.115437_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tetlet.2020.151857","article-title":"First total synthesis of the pro-resolving lipid mediator 7(S),12(R),13(S)-Resolvin T2 and its 13(R)-epimer Ana","volume":"61","author":"Rodriguez","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bcp.2023.115437_b0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.14-268441","article-title":"Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways","volume":"29","author":"Dalli","year":"2015","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b0645","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbalip.2014.08.006","article-title":"Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome charles","volume":"1851","author":"Serhan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2023.115437_b0650","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/Protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"J. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2023.115437_b0655","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.plefa.2009.05.024","article-title":"Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection","volume":"81","author":"Bazan","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"44","key":"10.1016\/j.bcp.2023.115437_b0660","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression *","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0665","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel pro-resolving aspirin-triggered DHA pathway Charles","volume":"18","author":"Serhan","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcp.2023.115437_b0670","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1021\/np500498j","article-title":"Synthesis and anti-in fl ammatory and pro-resolving activities of 22- OH-PD1, a monohydroxylated metabolite of protectin D1","volume":"77","author":"Tungen","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"January","key":"10.1016\/j.bcp.2023.115437_b0675","first-page":"1","article-title":"The protectin family of specialized pro-resolving mediators: potent immunoresolvents enabling innovative approaches to target obesity and diabetes","volume":"9","author":"Hansen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115437_b0680","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1021\/np4009865","article-title":"Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions marius","volume":"77","author":"Aursnes","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0685","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.chembiol.2018.04.017","article-title":"PD n-3 DPA pathway regulates human monocyte differentiation and macrophage function article PD n-3 DPA pathway regulates human monocyte differentiation and macrophage function","volume":"25","author":"Pistorius","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115437_b0690","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bmcl.2017.03.079","article-title":"Recent advances in the chemistry and biology of anti- inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid","volume":"27","author":"Vik","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b0695","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ajpath.2015.12.012","article-title":"The protectin PCTR1 is produced by human M2 macrophages and enhances resolution of infectious inflammation","volume":"186","author":"Ramon","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2023.115437_b0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2380319","article-title":"Maresins : Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases","volume":"2018","author":"Tang","year":"2018","journal-title":"Hindawi Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0705","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins : novel macrophage mediators with potent antiinfl ammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2023.115437_b0710","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0102362","article-title":"Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages","volume":"9","author":"Deng","year":"2014","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.bcp.2023.115437_b0720","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1073\/pnas.1607003113","article-title":"Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages","volume":"113","author":"Dalli","year":"2016","journal-title":"PNAS"},{"issue":"25","key":"10.1016\/j.bcp.2023.115437_b0725","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1016\/j.tetlet.2015.04.131","article-title":"First total synthesis of pro-resolving and tissue-regenerative Maresin","volume":"56","author":"Rodriguez","year":"2015","journal-title":"Tetrahedron Lett."},{"issue":"44","key":"10.1016\/j.bcp.2023.115437_b0730","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1073\/pnas.1415006111","article-title":"Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection","volume":"111","author":"Dalli","year":"2014","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0735","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12016-020-08796-4","article-title":"Specialized pro-resolving lipid mediators: emerging therapeutic candidates for multiple sclerosis","volume":"60","author":"Zahoor","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bcp.2023.115437_b0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution","volume":"13","author":"Serhan","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b0745","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4062\/biomolther.2021.094","article-title":"Specialized proresolving mediators for therapeutic interventions targeting metabolic and inflammatory disorders","volume":"29","author":"Han","year":"2021","journal-title":"Biomoelcules Ther."},{"key":"10.1016\/j.bcp.2023.115437_b0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08328-5","article-title":"Sympathetic nervous system controls resolution of inflammation via regulation of repulsive guidance molecule A","volume":"10","author":"K\u00f6rner","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2023.115437_b0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0765","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.smim.2015.03.014","article-title":"The resolution of inflammation: principles and challenges","volume":"27","author":"Headland","year":"2015","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0770","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/eji.201040801","article-title":"Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids","volume":"41","author":"Schif-zuck","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0775","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/joim.12871","article-title":"Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation","volume":"286","author":"Serhan","year":"2018","journal-title":"J. Int. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0780","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Pro-Resolving lipid mediators and Mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"issue":"162","key":"10.1016\/j.bcp.2023.115437_b0785","first-page":"1","article-title":"Lipoxin A 4 receptor stimulation attenuates neuroinflammation in a mouse model of intracerebral hemorrhage","volume":"12","author":"Futokoro","year":"2022","journal-title":"Brain Sci. MDPI"},{"issue":"278","key":"10.1016\/j.bcp.2023.115437_b0790","first-page":"1","article-title":"Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines","volume":"9","author":"Hu","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2023.115437_b0795","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","article-title":"Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages","volume":"164","author":"Godson","year":"2000","journal-title":"J. Immunol."},{"issue":"10370","key":"10.1016\/j.bcp.2023.115437_b0800","first-page":"1","article-title":"specialized pro-resolving lipid mediators : the future of chronic pain therapy ?","volume":"22","author":"Chavaz-castillo","year":"2021","journal-title":"Int. J. Mol. Sci. MDPI"},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b0805","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/SHK.0b013e31822798c1","article-title":"Lipoxin A4 increases survival by decreasing systemic inflammation and bacterial load in sepsis","volume":"36","author":"Walker","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.bcp.2023.115437_b0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00060","article-title":"Modulation of neutrophil apoptosis and the resolution of inflammation through \u03b22 integrins","volume":"4","author":"El Kebir","year":"2013","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0815","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1096\/fj.12-223982","article-title":"15-Epi-lipoxin A 4 inhibits human neutrophil superoxide anion generation by regulating polyisoprenyl diphosphate phosphatase 1","volume":"27","author":"Carlo","year":"2013","journal-title":"FASEB J."},{"issue":"20","key":"10.1016\/j.bcp.2023.115437_b0820","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.202296999","article-title":"Lipoxin A 4 and aspirin-triggered 15-epi-lipoxin A 4 inhibit peroxynitrite formation, NF- kB and AP-1 activation, and IL-8 gene expression in human leukocytes","volume":"99","author":"Jozsef","year":"2002","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0825","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0002-9440(10)61175-3","article-title":"Lipoxins Induce Actin Reorganization in Monocytes and Macrophages But Not in Neutrophils Differential Involvement of Rho GTPases","volume":"160","author":"Maderna","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2023.115437_b0830","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","article-title":"Lipoxins, Aspirin-Triggered Epi-Lipoxins, Lipoxin Stable Analogues, and the Resolution of Inflammation : Stimulation of Macrophage Phagocytosis of Apoptotic Neutrophils In Vivo","volume":"13","author":"Mitchell","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0835","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)63181-1","article-title":"Lipoxins inhibit Akt\/PKB activation and cell cycle progression in human mesangial cells","volume":"164","author":"Mitchell","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b0840","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.4049\/jimmunol.164.5.2660","article-title":"Lipoxin A 4 inhibits IL-1\u03b2-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases","volume":"164","author":"Sodin-Semrl","year":"2000","journal-title":"J. Immunol."},{"issue":"51","key":"10.1016\/j.bcp.2023.115437_b0845","doi-asserted-by":"crossref","first-page":"21134","DOI":"10.1073\/pnas.1202906109","article-title":"Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor","volume":"109","author":"Pamplona","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2023.115437_b0850","first-page":"1","article-title":"The lipoxin A4 receptor agonist BML-111 alleviates inflammatory injury and oxidative stress in spinal cord injury","volume":"26","author":"Liu","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bcp.2023.115437_b0855","first-page":"1","article-title":"Lipoxins in the nervous system: brighter prospects for neuroprotection","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"658840","key":"10.1016\/j.bcp.2023.115437_b0860","first-page":"1","article-title":"Resolution-based therapies: the potential of lipoxins to treat human diseases","volume":"12","author":"Ja\u00e9n","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b0865","first-page":"181","article-title":"Lipoxins: Nature\u2019s way to resolve inflammation","volume":"8","author":"Chandrasekharan","year":"2015","journal-title":"J. Inflamm. Res."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b0870","first-page":"1","article-title":"Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases","volume":"1866","author":"Andrews","year":"2021","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.202101219RR","article-title":"Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis","volume":"36","author":"Kraft","year":"2022","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b0880","first-page":"1","article-title":"Specialized pro-resolving lipid mediators: new therapeutic approaches for vascular remodeling","volume":"23","author":"Del Campo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0885","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jdermsci.2018.04.014","article-title":"Lipoxin A4 inhibits UV radiation-induced skin inflammation and oxidative stress in mice","volume":"91","author":"Martinez","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bcp.2023.115437_b0890","first-page":"1","article-title":"Proresolving lipid mediators: Endogenous modulators of oxidative stress","volume":"2019","author":"Leuti","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2023.115437_b0895","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroscience.2015.04.060","article-title":"Lipoxin A4 attenuates radicular pain possibly by inhibiting spinal ERK, JNK and NF-\u03baB\/P65 and cytokine signals, but not P38, in a rat model of non-compressive lumbar disc herniation","volume":"300","author":"Miao","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0900","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","article-title":"Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease","volume":"22","author":"B\u00f6rgeson","year":"2015","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.bcp.2023.115437_b0905","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2337\/db17-1317","article-title":"Lipoxins protect against inflammation in diabetes-associated atherosclerosis","volume":"67","author":"Brennan","year":"2018","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0910","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B 4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J. Immunol."},{"issue":"May","key":"10.1016\/j.bcp.2023.115437_b0915","first-page":"1","article-title":"Role of resolvins in the inflammatory resolution of neurologiocal diseases","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b0920","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/BJ20110327","article-title":"Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution","volume":"437","author":"Fredman","year":"2011","journal-title":"Biochem. J"},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b0925","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ibd.21029","article-title":"Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis","volume":"16","author":"Ishida","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b0930","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1074\/jbc.M109.044131","article-title":"Resolvin E1 receptor activation signals phosphorylation and phagocytosis","volume":"285","author":"Ohira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115437_b0935","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.fob.2012.10.001","article-title":"Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress","volume":"2","author":"Takamiya","year":"2012","journal-title":"FEBS Open Bio"},{"issue":"37","key":"10.1016\/j.bcp.2023.115437_b0940","doi-asserted-by":"crossref","first-page":"14983","DOI":"10.1073\/pnas.1206641109","article-title":"Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation","volume":"109","author":"El Kebir","year":"2012","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b0945","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvinas en Inflamaci\u00f3n: Emergencia de la superfamilia de mediadores de resoluci\u00f3n pro","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b0950","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"476","key":"10.1016\/j.bcp.2023.115437_b0955","first-page":"1","article-title":"Pro-resolving molecules\u2014New approaches to treat sepsis?","volume":"18","author":"Buechler","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b0960","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/glia.23779","article-title":"RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome","volume":"68","author":"Hamlett","year":"2020","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.bcp.2023.115437_b0965","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.4049\/jimmunol.1103652","article-title":"Resolvin E2 formation and impact in inflammation-resolution","volume":"188","author":"Oh","year":"2012","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b0970","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","article-title":"Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving MicroRNAs","volume":"180","author":"Krishnamoorthy","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2023.115437_b0975","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1476-5381.2010.00909.x","article-title":"Resolvin D1 attenuates activation of sensory transient receptor potential anti-nociception","volume":"161","author":"Bang","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b0980","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1096\/fj.10-178657","article-title":"Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice","volume":"25","author":"Hellmann","year":"2011","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b0985","first-page":"868","article-title":"Increased dietary intake of \u03c9-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b0990","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bcp.2013.07.002","article-title":"Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis","volume":"86","author":"Lee","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"May","key":"10.1016\/j.bcp.2023.115437_b0995","first-page":"1","article-title":"Resolvin D1 improves the Treg \/ Th17 imbalance in systemic lupus erythematosus through miR-30e-5p","volume":"12","author":"Cheng","year":"2021","journal-title":"Front. Immunol."},{"issue":"239","key":"10.1016\/j.bcp.2023.115437_b1000","first-page":"1","article-title":"Functions of resolvin D1-ALX \/ FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"390","key":"10.1016\/j.bcp.2023.115437_b1005","first-page":"1","article-title":"Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways","volume":"3","author":"Levy","year":"2012","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b1010","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J. Exp. Med."},{"issue":"7395","key":"10.1016\/j.bcp.2023.115437_b1015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115437_b1020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2018.07.016","article-title":"Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma","volume":"139","author":"Ye","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2023.115437_b1025","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.2147\/DDDT.S329507","article-title":"Activation of GPR18 by resolvin D2 relieves pain and improves bladder function in cyclophosphamide-induced cystitis through inhibiting TRPV1","volume":"15","author":"Lu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b1030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41590-019-0356-7","article-title":"Dynamic lipid mediator changes support macrophage subtype transitions during muscle regeneration Nikolas","volume":"20","author":"Gionnakis","year":"2019","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1035","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s43440-021-00271-x","article-title":"Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology","volume":"73","author":"Tylek","year":"2021","journal-title":"Pharmacol. Reports"},{"issue":"24","key":"10.1016\/j.bcp.2023.115437_b1040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI142883","article-title":"The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection","volume":"131","author":"Arnardottir","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b1045","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.ajpath.2016.03.011","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are protective for injured epithelia","volume":"186","author":"Colby","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"17","key":"10.1016\/j.bcp.2023.115437_b1050","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2018886317","article-title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","volume":"134","author":"Cherpokova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115437_b1055","article-title":"Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation Jeremy","author":"Winkler","year":"2019","journal-title":"J Leuko Biol"},{"key":"10.1016\/j.bcp.2023.115437_b1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.00745","article-title":"Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: distinct actions of D-series resolvins in chemotherapy- induced peripheral neuropathy","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4014\/jmb.1907.07033","article-title":"Resolvin D5, a Lipid mediator, inhibits production of interleukin-6 and CCL5 via the ERK-NF-\u03baB signaling pathway in lipopolysaccharide- stimulated THP-1 Cells","volume":"30","author":"Chun","year":"2020","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bcp.2023.115437_b1070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-96530-1","article-title":"Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis","volume":"11","author":"Yamada","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115437_b1075","first-page":"1","article-title":"Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome, Egypt","volume":"35","author":"Pham","year":"2021","journal-title":"J. Hosp. Med."},{"issue":"12","key":"10.1016\/j.bcp.2023.115437_b1080","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1085","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI124219","article-title":"A maresin 1 \/ ROR \u03b1 \/ 12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis","volume":"129","author":"Han","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b1090","first-page":"1","article-title":"MAR1 suppresses inflammatory response in LPS-induced RAW 264. 7 macrophages and human primary peripheral blood mononuclear cells via the SIRT1 \/ PGC-1 \u03b1 \/ PPAR- \u03b3 pathway","volume":"18","author":"Wang","year":"2021","journal-title":"J. Inflamm."},{"key":"10.1016\/j.bcp.2023.115437_b1095","first-page":"1","article-title":"Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4 \/ NF-kB signaling pathway","volume":"78","author":"Qiu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2560","key":"10.1016\/j.bcp.2023.115437_b1100","first-page":"2","article-title":"Maresin1 suppresses high-glucose-induced ferroptosis in osteoblasts via NRF2 activation in Type 2 diabetic osteoporosis","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4049\/jimmunol.1402534","article-title":"Maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation","volume":"194","author":"Krishnamoorthy","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b1110","first-page":"1","article-title":"Maresin 1 alleviates diabetic kidney disease via LGR6-mediated cAMP-SOD2-ROS pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Hindawi Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2023.115437_b1115","first-page":"1","article-title":"Maresin 1 inhibits TRPV1 in temporomandibular joint-related trigeminal nociceptive neurons and TMJ inflammation-induced synaptic plasticity in the trigeminal nucleus","volume":"2015","author":"Park","year":"2015","journal-title":"Mediat. Inflammation, Hindawi"},{"issue":"831","key":"10.1016\/j.bcp.2023.115437_b1120","first-page":"1","article-title":"Maresin 1 attenuates radicular pain through the inhibition of NLRP3 inflammasome-induced pyroptosis via NF- \u03ba B signaling","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1367","key":"10.1016\/j.bcp.2023.115437_b1125","first-page":"1","article-title":"Maresin-1 and inflammatory disease","volume":"23","author":"Saito-sasaki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115437_b1130","doi-asserted-by":"crossref","unstructured":"W. A. Fattori, V., Zaninelli, T. H., Ferraz, C. R., Brasil-Silva, L., Borghi, S. M., Cunha, J. M., ... & Verri Jr, \u201cMaresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release,\u201d Neuropharmacology, vol. 216, 2022, doi: https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109189.","DOI":"10.1016\/j.neuropharm.2022.109189"},{"issue":"6233","key":"10.1016\/j.bcp.2023.115437_b1135","first-page":"1","article-title":"Signaling pathways used by the specialized pro-resolving mediator maresin 2 regulate goblet cell function: Comparison with maresin 1","volume":"23","author":"Olsen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2009.10.010","article-title":"Neuroprotectin D1\/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils","volume":"82","author":"Marcheselli","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"52","key":"10.1016\/j.bcp.2023.115437_b1145","doi-asserted-by":"crossref","first-page":"43079","DOI":"10.1074\/jbc.M509796200","article-title":"The docosatriene protectin D1 is produced by TH2 skewing promotes human T cell via lipid raft clustering","volume":"280","author":"Ariel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115437_b1150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuroscience.2021.04.026","article-title":"Bioactive lipid mediators in the initiation and resolution of inflammation after spinal cord injury","volume":"466","author":"David","year":"2021","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b1155","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"August","key":"10.1016\/j.bcp.2023.115437_b1160","article-title":"Protectins: Their biosynthesis, metabolism and structure-functions","volume":"206","author":"Vidar Hansen","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1165","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b1170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1750-3639.2005.tb00513.x","article-title":"Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress","volume":"15","author":"Bazan","year":"2005","journal-title":"Brain Pathol."},{"issue":"SUPPL","key":"10.1016\/j.bcp.2023.115437_b1175","article-title":"Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer\u2019s disease","volume":"50","author":"Bazan","year":"2009","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b1180","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"November","key":"10.1016\/j.bcp.2023.115437_b1185","first-page":"1","article-title":"Neuroprotectin D1 Protects Against Postoperative Delirium-Like Behavior in Aged Mice","volume":"12","author":"Zhou","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"May","key":"10.1016\/j.bcp.2023.115437_b1190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2022.09.021","article-title":"Macrophages undergo a behavioural switch during wound healing in zebrafish","volume":"192","author":"Sipka","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"42","key":"10.1016\/j.bcp.2023.115437_b1195","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1523\/JNEUROSCI.2443-11.2011","article-title":"Resolving TRPV1- and TNF-\u03b1-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2023.115437_b1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115181","article-title":"A newly synthesized 17-epi-NeuroProtectin D1\/17-epi-Protectin D1: authentication and functional regulation of Inflammation-Resolution","volume":"203","author":"Hamidzadeh","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2012.04.007","article-title":"Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke","volume":"236","author":"Bazan","year":"2012","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b1210","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1007\/s12035-018-1136-3","article-title":"Docosanoids promote neurogenesis and angiogenesis, blood- brain barrier integrity, penumbra protection and neurobehavioral recovery after experimental ischemic stroke","volume":"55","author":"Belayev","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.202101815R","article-title":"Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor","volume":"36","author":"Mikroulis","year":"2022","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2013374118","article-title":"Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation","volume":"118","author":"Chiang","year":"2021","journal-title":"PNAS"},{"issue":"February","key":"10.1016\/j.bcp.2023.115437_b1225","first-page":"1","article-title":"Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function","volume":"177","author":"Yang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115437_b1230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10555-021-10017-z","article-title":"COVID - 19 and cancer: start the resolution !","volume":"41","author":"Barksdale","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b1235","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators Resolvins in inflammation : emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"23","key":"10.1016\/j.bcp.2023.115437_b1240","first-page":"2255","article-title":"\u201cCytokine Storm\u201d, new engl","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"J. Med. Rev."},{"key":"10.1016\/j.bcp.2023.115437_b1245","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"13009","key":"10.1016\/j.bcp.2023.115437_b1250","first-page":"1","article-title":"Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases","volume":"22","author":"Tang","year":"2021","journal-title":"Int. J. Mol. Sci. MDPI"},{"issue":"56","key":"10.1016\/j.bcp.2023.115437_b1255","first-page":"1","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-vornhagen","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b1260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0253894","article-title":"Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis","volume":"16","author":"Melo","year":"2021","journal-title":"PLoS One"},{"issue":"2318","key":"10.1016\/j.bcp.2023.115437_b1265","first-page":"1","article-title":"The roles of neutrophils in cytokine storms","volume":"13","author":"Chan","year":"2021","journal-title":"Viruses MDPI"},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_b1270","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2023.115437_b1275","first-page":"1","article-title":"Perforin, COVID- 19 and a possible pathogenic auto- inflammatory feedback loop","volume":"94","author":"Cunningham","year":"2021","journal-title":"Scand. Found. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b1280","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsps.2020.12.018","article-title":"Immune system response during viral infections: immunomodulators, cytokine storm (CS) and immunotherapeutics in COVID-19","volume":"29","author":"Hyder Potoo","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bcp.2023.115437_b1285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.aca.2014.10.009","article-title":"Bioanalytical chemistry of cytokines-a review julie","volume":"853","author":"Stenken","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.bcp.2023.115437_b1290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2020.106749","article-title":"Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19","volume":"86","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2023.115437_b1295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800100-4.00001-5","article-title":"Multifarious determinants of cytokine receptor signaling specificity","volume":"121","author":"Moraga","year":"2014","journal-title":"Adv. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_b1300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int Anesth. Clin"},{"issue":"491","key":"10.1016\/j.bcp.2023.115437_b1305","first-page":"1","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Duque","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/VIW.20210003","article-title":"Point-of-care detection of cytokines in cytokine storm management and beyond: significance and challenges","volume":"2","author":"Liu","year":"2021","journal-title":"View"},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/109980040000200104","article-title":"Understanding cytokines Part I: physiology and mechanism of action","volume":"2","author":"Corwin","year":"2000","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.bcp.2023.115437_b1320","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2174\/1381612013397573","article-title":"Role of cytokines and cytokine therapy in wound healing and fibrotic diseases","volume":"7","author":"Gharaee-kermani","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2023.115437_b1325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1721727X221098970","article-title":"Immune response and cytokine storm in SARS-CoV-2 infection: risk factors, ways of control and treatment","volume":"20","author":"Chegni","year":"2022","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.bcp.2023.115437_b1330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"673","key":"10.1016\/j.bcp.2023.115437_b1335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.abc5763","article-title":"Identification of human immune cell subtypes most responsive to IL-1\u03b2-induced inflammatory signaling using mass cytometry","volume":"14","author":"Kothari","year":"2021","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1340","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12291-021-00989-8","article-title":"Interleukin-6 perpetrator of the COVID-19 cytokine storm","volume":"36","author":"Shekhawat","year":"2021","journal-title":"Indian J. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10753-020-01337-3","article-title":"Inflammation Triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications","volume":"44","author":"Iwasaki","year":"2021","journal-title":"Inflammation"},{"issue":"1057","key":"10.1016\/j.bcp.2023.115437_b1350","first-page":"1","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Velazquez-salinas","year":"2019","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1355","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.gendis.2020.06.009","article-title":"ScienceDirect coronavirus disease 2019 (COVID-19): phenotypes, and acute respiratory distress syndrome","volume":"7","author":"Lin","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.bcp.2023.115437_b1360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcp.2023.115437_b1365","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41435-021-00140-w","article-title":"Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome \u2014 with a preliminary reference to SARS-CoV-2 pneumonia","volume":"22","author":"Land","year":"2021","journal-title":"Genes Immun."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b1370","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1515\/jom-2020-0292","article-title":"The role of tocilizumab therapy in critically ill patients with severe acute respiratory syndrome","volume":"121","author":"Saffo","year":"2021","journal-title":"J Osteopat. Med"},{"key":"10.1016\/j.bcp.2023.115437_b1375","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin - converting enzyme 2 (ACE2) as a SARS - CoV - 2 receptor : molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.bcp.2023.115437_b1380","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jmv.27405","article-title":"Role of toll - like receptors in modulation of cytokine storm signaling in SARS - CoV - 2 - induced COVID - 19","volume":"94","author":"Manik","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2023.115437_b1385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Costela-ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"624483","key":"10.1016\/j.bcp.2023.115437_b1390","first-page":"1","article-title":"T-helper cell subset response is a determining factor in COVID-19 Progression","volume":"11","author":"Gil-etayo","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1395","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection Ana","volume":"146","author":"Copaescu","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"112419","key":"10.1016\/j.bcp.2023.115437_b1400","first-page":"1","article-title":"Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications","volume":"145","author":"Majidpoor","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"613422","key":"10.1016\/j.bcp.2023.115437_b1405","first-page":"1","article-title":"Interleukin-6 Is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front. Immunol."},{"issue":"100029","key":"10.1016\/j.bcp.2023.115437_b1410","first-page":"1","article-title":"SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the \u2018 culprit lesion \u2019 of ARDS onset ? What is there besides Tocilizumab ? SGP130Fc","volume":"2","author":"Magro","year":"2020","journal-title":"Cytokine X"},{"key":"10.1016\/j.bcp.2023.115437_b1415","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"827","key":"10.1016\/j.bcp.2023.115437_b1420","first-page":"1","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_b1425","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019 Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"596631","key":"10.1016\/j.bcp.2023.115437_b1430","first-page":"1","article-title":"Sharing CD4 + T cell loss: when COVID-19 and HIV collide on immune system","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1435","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5937\/jomb0-27554","article-title":"C-REACTIVE PROTEIN AS AN EARLY PREDICTOR OF COVID-19 SEVERITY","volume":"39","author":"Ahnach","year":"2020","journal-title":"J Med Biochem"},{"key":"10.1016\/j.bcp.2023.115437_b1440","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12272-020-01299-y","article-title":"Role of specialized pro - resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS - CoV - 2 cytokine storm","volume":"44","author":"Lee","year":"2021","journal-title":"Arch. Pharm. Res."},{"issue":"8","key":"10.1016\/j.bcp.2023.115437_b1445","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4103\/0366-6999.229890","article-title":"Specialized pro - resolving mediators regulate alveolar fluid clearance during acute respiratory distress syndrome","volume":"131","author":"Wang","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bcp.2023.115437_b1450","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbalip.2015.01.006","article-title":"Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection","volume":"1851","author":"Imai","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1455","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2013.02.027","article-title":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza","volume":"153","author":"Morita","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1460","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","article-title":"Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1","volume":"186","author":"Rajasagi","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115437_b1465","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1167\/iovs.13-12152","article-title":"Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology","volume":"54","author":"Rajasagi","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1470","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/mi.2013.71","article-title":"Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology","volume":"7","author":"Shirey","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1475","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cbin.10345","article-title":"Roles of resolvins in the resolution of acute inflammation","volume":"39","author":"Qu","year":"2015","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bcp.2023.115437_b1480","doi-asserted-by":"crossref","unstructured":"M. C. p Sok, M. c Tria, C. E. Olingy, C. L. San Emetereio, and E. A. Botchwey, \u201cAspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling, Acta Biomater 53 (2017) 109\u2013122, doi: 10.1016\/j.actbio.2017.02.020.Aspirin-Triggered.","DOI":"10.1016\/j.actbio.2017.02.020"},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1485","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1490","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2009.00290.x","article-title":"Resolvins and protectins: Mediating solutions to inflammation","volume":"158","author":"Kohli","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1500","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2133.2012.11177.x","article-title":"Efficacy and safety of 15(R\/S)-methyl-lipoxin A4 in topical treatment of infantile eczema","volume":"168","author":"Wu","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1505","doi-asserted-by":"crossref","first-page":"746","DOI":"10.14336\/AD.2020.0521","article-title":"Bioactive lipids as mediators of the beneficial action(s) of mesenchymal stem cells in COVID-19","volume":"11","author":"Das","year":"2020","journal-title":"Aging Dis."},{"issue":"10","key":"10.1016\/j.bcp.2023.115437_b1510","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.1003865","article-title":"Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing","volume":"186","author":"Norling","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_b1515","unstructured":"A. T. R. SARL, \u201cEfficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery, calTrials.gov Identifier:, vol. ClinicalTr, no. Available online: clinicaltrials.gov, p. accessed on 25 Nov, 2022, 2019."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.202001952R","article-title":"Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages","volume":"35","author":"Recchiuti","year":"2021","journal-title":"FASEB J."},{"issue":"5207","key":"10.1016\/j.bcp.2023.115437_b1525","first-page":"1","article-title":"Polyunsaturated \u03c9-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry","volume":"11","author":"Goc","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_b1530","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jpen.1871","article-title":"Parenteral fish-oil emulsions in critically Ill COVID-19 emulsions","volume":"44","author":"Bistrian","year":"2020","journal-title":"J. Parenter. Enter. Nutr."},{"issue":"9","key":"10.1016\/j.bcp.2023.115437_b1535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ctm2.895","article-title":"Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: a single-blind randomized controlled trial","volume":"12","author":"Arnardottir","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1540","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.arcmed.2020.09.006","article-title":"Bioactive lipids in COVID-19-further evidence","volume":"52","author":"Das","year":"2021","journal-title":"Arch. Med. Res."},{"issue":"January","key":"10.1016\/j.bcp.2023.115437_b1545","first-page":"1","article-title":"Stimulating the resolution of inflammation through omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-omega-F trial","volume":"11","author":"Arnardottir","year":"2021","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1550","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2023.115437_b1555","doi-asserted-by":"crossref","unstructured":"S. Pawelzik et al., Decreased oxidative stress and altered urinary oxylipidome by intravenous omega-3 fatty acid emulsion in a randomized controlled trial of older subjects hospitalized for COVID-19, Free Radic. Biol. Med., vol. 194, no. November 2022, pp. 308\u2013315, 2023, doi: 10.1016\/j.freeradbiomed.2022.12.006.","DOI":"10.1016\/j.freeradbiomed.2022.12.006"},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1560","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12325-022-02042-3","article-title":"A new approach to the management of COVID-19. antagonists of IL-6: siltuximab","volume":"39","author":"Villaescusa","year":"2022","journal-title":"Adv. Ther."},{"issue":"468","key":"10.1016\/j.bcp.2023.115437_b1565","first-page":"1","article-title":"Erratum: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial (Trials (2020) 21 468 DOI: 10.1186\/s13063-020-04453-5)","volume":"21","author":"Maes","year":"2020","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.bcp.2023.115437_b1570","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S2213-2600(21)00377-5","article-title":"Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial","volume":"9","author":"Declercq","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115437_b1575","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jama.2021.9508","article-title":"Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19....A randomized clinical trial","volume":"326","author":"Caricchio","year":"2021","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_b1580","first-page":"1","article-title":"Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation","volume":"1","author":"Cremer","year":"2021","journal-title":"Eur. Hear. J. Open"},{"issue":"108172","key":"10.1016\/j.bcp.2023.115437_b1585","first-page":"1","article-title":"Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl\/eicosapentaenoic acid","volume":"237","author":"Chapman","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2023.115437_b1590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/AJCR.928422","article-title":"Three cases of covid-19 pneumonia that responded to icosapent ethyl supportive treatment","volume":"21","author":"Suh","year":"2020","journal-title":"Am. J. Case Rep."},{"issue":"9","key":"10.1016\/j.bcp.2023.115437_b1595","first-page":"10","article-title":"Icosapent ethyl \u2013 a successful treatment for symptomatic COVID-19 infection","volume":"12","author":"Berger","year":"2020","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_b1600","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1161\/CIRCRESAHA.121.319142","article-title":"Disrupted resolution mechanisms favor altered phagocyte responses in COVID-19","volume":"129","author":"Koenis","year":"2021","journal-title":"Circ. Res."},{"issue":"7146","key":"10.1016\/j.bcp.2023.115437_b1605","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and Protectin D1 Activate Inflammation-Resolution","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2023.115437_bib1609","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro- resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_bib1610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.201900283R","article-title":"Resolvin E3 attenuates allergic airway inflammation via the interleukin-23 \u2013 interleukin-17A pathway","volume":"33","author":"Sato","year":"2019","journal-title":"Faseb J."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_bib1611","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jphs.2018.09.006","article-title":"Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice","volume":"138","author":"Deyama","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"1273","key":"10.1016\/j.bcp.2023.115437_bib1612","first-page":"1","article-title":"Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease","volume":"9","author":"Pirault","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115437_bib1613","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.chembiol.2018.10.023","article-title":"Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions","volume":"26","author":"Chiang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bcp.2023.115437_bib1614","first-page":"830930","article-title":"Biological Roles of Resolvins and Related Substances in the Resolution of Pain","author":"Lim","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"17","key":"10.1016\/j.bcp.2023.115437_bib1615","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2018886317","article-title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","volume":"134","author":"Cherpokova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115437_bib1616","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2022.154091","article-title":"First total synthesis of 4(R),17(R)-Resolvin D6 stereoisomer, a potent neuroprotective docosanoid","volume":"106","author":"Nshimiyimana","year":"2022","journal-title":"Tetrahedron Lett."},{"issue":"6","key":"10.1016\/j.bcp.2023.115437_bib1617","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.2001228","article-title":"AT-RvD1 Mitigates Secondhand Smoke\u2013Exacerbated Pulmonary Inflammation and Restores Secondhand Smoke\u2013Suppressed Antibacterial Immunity","volume":"206","author":"Bhat","year":"2021","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115437_bib1618","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.4049\/jimmunol.1400942","article-title":"Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and its Analogue, 17R-Hydroxy-19-Para-Fluorophenoxy-Resolvin D1 Methyl Ester, in C5a-dependent IgG Immune Complex-Induced Inflammation and Lung Injury Huifang","volume":"193","author":"Tang","year":"2014","journal-title":"J.Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_bib1619","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.4049\/jimmunol.1101665","article-title":"Resolvin D1 and its aspirin-triggered epimer AT-RvD1 promote the resolution of allergic airways responses","volume":"189","author":"Rogerio","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_bib1620","first-page":"1","article-title":"Protectin DX promotes the inflammatory resolution via activating COX-2\/ L-PGDS-PGD2 and DP1 receptor in acute respiratory distress syndrome","volume":"102","author":"Hu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2023.115437_bib1621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2018.09.011","article-title":"Protectin DX prevents H2O2-mediated oxidative stress in vascular endothelial cells via an AMPK-dependent mechanism","volume":"53","author":"Hwang","year":"2019","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_bib1622","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/mi.2014.116","article-title":"Lipoxin B4 promotes the resolution of allergic inflammation in the upper and lower airways of mice","volume":"8","author":"Karra","year":"2015","journal-title":"Nat. Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_bib1623","first-page":"1","article-title":"IFN- c in the Brain","volume":"8","author":"Shryock","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115437_bib1624","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.preghy.2021.09.003","article-title":"Low-dose aspirin increases 15-epi-lipoxins A4 in pregnancies at high-risk for developing preeclampsia","volume":"26","author":"Gonzalez-Brown","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.bcp.2023.115437_bib1625","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution","volume":"73","author":"Serhan","year":"2005","journal-title":"Prostaglandins Leukot Essent Fat. Acids"},{"issue":"585530","key":"10.1016\/j.bcp.2023.115437_bib1626","first-page":"1","article-title":"Maresin-1 and Resolvin E1 Promote Regenerative Properties of Periodontal Ligament Stem Cells Under Inflammatory Conditions","volume":"11","author":"Albuquerque-Souza","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_bib1627","first-page":"7442","article-title":"Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential","volume":"24","author":"Li","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2023.115437_bib1628","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2147\/JIR.S304811","article-title":"MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice","volume":"14","author":"Pan","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bcp.2023.115437_bib1629","doi-asserted-by":"crossref","first-page":"9646","DOI":"10.1111\/jcmm.15481","article-title":"MCTR1 enhances the resolution of lipopolysaccharide-induced lung injury through STAT6-mediated resident M2 alveolar macrophage polarization in mice","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_bib1630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0149319","article-title":"Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration","volume":"11","author":"Dalli","year":"2016","journal-title":"PLoS One"},{"issue":"193","key":"10.1016\/j.bcp.2023.115437_bib1631","first-page":"1","article-title":"Protectin conjugates in tissue regeneration 1 restores lipopolysaccharide _ induced pulmonary endothelial glycocalyx loss via ALX \/ SIRT1 \/ NF _ kappa B axis","volume":"22","author":"Wang","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.bcp.2023.115437_bib1632","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2017.10.007","article-title":"Immunoresolvents signaling molecules at intersection between the brain and immune system","volume":"50","author":"Dalli","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_bib1634","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1124\/jpet.121.000712","article-title":"Resolvin Conjugates in Tissue Regeneration 1 Promote Alveolar Fluid Clearance by Activating Alveolar Epithelial Sodium Channels and Na, K-ATPase in Lipopolysaccharide-Induced Acute Lung Injury","volume":"379","author":"Yang","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2023.115437_bib1635","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ajpath.2018.01.004","article-title":"Identi fi cation and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration","volume":"188","author":"De Rosa","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2023.115437_bib1636","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2021.677008","article-title":"Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?","volume":"12","author":"Islam","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115437_bib1637","doi-asserted-by":"crossref","first-page":"198171","DOI":"10.1016\/j.virusres.2020.198171","article-title":"IFN-\u03b3 is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection","volume":"289","author":"Carolina","year":"2020","journal-title":"Virus research"},{"issue":"102099","key":"10.1016\/j.bcp.2023.115437_bib1638","first-page":"1","article-title":"Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells","volume":"46","author":"Youn","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2023.115437_bib1639","first-page":"1","article-title":"Targeting TNF-\u03b1 for COVID-19: Recent Advanced and Controversies","volume":"10","author":"Guo","year":"2022","journal-title":"Front. Public Heal."},{"issue":"2","key":"10.1016\/j.bcp.2023.115437_bib1640","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ije\/dyab012","article-title":"The role of C-reactive protein as a prognostic marker in COVID-19","volume":"50","author":"Stringer","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bcp.2023.115437_bib1641","first-page":"1","article-title":"Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients","volume":"13","author":"Fan","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115437_bib1642","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/13696998.2022.2030148","article-title":"Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective","volume":"25","author":"Kilcoyne","year":"2022","journal-title":"J. Med. Econ."},{"issue":"12","key":"10.1016\/j.bcp.2023.115437_bib1643","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9122615","article-title":"Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients","volume":"9","author":"Kwiecie\u0144","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115437_bib1644","first-page":"1","article-title":"Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:17:25Z","timestamp":1762096645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522300028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":356,"alternative-id":["S000629522300028X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115437","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115437"}}